[1] Lloyd-Jones D, Adams R J, Brown TM, et al. Executive summary:heart disease and stroke statistics——2010 update:a report from the American Heart Association. Circulation, 201 O, 12 l(7):948-954.
[2] 管阳太.动脉粥样硬化血栓形成与脑卒中的抗血小板治疗.上海医学,2009(4):271-275.
[3] Libby P. Current concepts of the pathogenesis of the acute coronary. syndromes. Circulation, 2001, 104(3):365-372.
[4] Cheng C, Tempel D, van Haperen R, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation, 2006, 113(23):2744-2753.
[5] Muller JE, Toiler GH. Triggering and hourly variation of onset of arterial thrombosis. Ann Epidemiol, 1992, 2(4):393-405.
[6] Muller JE, Kaufnmnn PG, Luepker RV, et al. Mechanisms precipitating acute cardiac events:review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms precipitating acute cardiac events participants. Circulation, 1997, 96(9):3233-3239.
[7] Matter CM, Stuber M, Nahrendorf M. Imaging of the unstable plaque:how far have we got?. Eur Heart J, 2009, 30(21):2566-2574.
[8] 宋桂芹,王拥军.识别易损斑块的影像技术.中华老年心脑血管病杂志,2008,10(11):875-877.
[9] Budoff M J, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography:a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation, 2006, 114(16):1761-1791.
[10] Ohtsuki K, Hayase M, Akashi K, et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotie lesions:an autoradiographic study. Circulation, 2001, 104(2):203-208.
[11] Iuliano L, Signore A, Vallabajosula S, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis, 1996, 126(1):131-141.
[12] Johnson LL, Sehofield L, Donahay T, et al. ^99mTc-annexin V imaging for in vivo detection of atherosclero'de lesions in porcine coronary arteries. J Nuel Med, 2005, 46(7):1186-1193.
[13] Kietselaer BL, Reutelingsperger CP, Heidendal GA, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 patients with carotid-artery atheroselerosis. N Engl J Med, 2004, 350(14):1472-1473.
[14] Ogawa M, Ishino S, Mukai T, et al. (18)F-FDG accumulation in atherosclerotie plaques:immunohistoehemieal and PET imaging study. J Nuel Med, 2004, 45(7):1245-1250.
[15] Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivomeasurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol, 2005, 12(3):294301.
[16] Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coil Cardiol, 2006, 48(9):1818-1824.
[17] Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atheroscterotic plaques with FDG-microPET:No FDG accumulation. Atherosclerosis, 2007, 192(2):275-282.
[18] Manieri M, Murano I, Fianchini A, et ah Morphological and immunohistochemicat features of brown adipocytes and preadipocytes in a case of human hibernoma. Nutr Metab Cardiovasc Dis, 2010, 20(8):567-574.
[19] Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab, 2007, 293(2):E444-E452.
[20] Graebe M, Pedersen SF, Borgwardt L, et al. Moleeular pathology in vulnerable carotid plaques:correlation with[18]-fluorodeoxvglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg, 2009, 37(6):714-721.
[21] Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed, 2006, 19(6):636-654.
[22] Yuan C, Oikawa M, Miller Z, et al. MRI of carotid atherosclerosis. J Nucl Cardiol, 2008, 15(2):266-275.
[23] Chu B, Kampschulte A, Ferguson MS, et al. Hemorrhage in the atherosclerotic carotid plaque:a high-resolution MRI study. Stroke, 2004, 35(5):1079-1084.
[24] Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo muhicontrast magnetic resonance imaging. Circulation, 2002, 106(11):1368-1373.
[25] 赵辉林,许建荣.3.0T高分辨MRI对颈动脉斑块分型的研究.中国医学计算机成像杂志,2007,13(3):158-162.
[26] Yarnykh VL, Terashima M, Hayes CE, et al. Muhicontrast blackblood MR/of carotid arter/es:comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Resort Imaging, 2006, 23(5):691-698.
[27] Redgrave JN, Gallagher P, Lovett JK, et al. Critical cap thickness and rupture in symptomatic carotid plaques:The oxford plaque study. Stroke, 2008, 39(6):1722-1729.
[28] No authors listed. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA, 1995,273(18):1421-1428.
[29] European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptonmtic carotid stenosis:final results of the MRC European Carotid Surgery Trial (ECST). Lancet, 1998, 351(9113):1379-1387.